Table 2.
Comparison of stroke-related complications and outcomes between patients with and without COVID-19.
| Variables | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
| COVID-19 status | COVID-19 status | |||||
| Non-COVID-19 (N = 711) | COVID-19 (N = 109) | p | Non-COVID-19 (N = 218) | COVID-19 (N = 109) | p | |
| Pneumonia, n (%) | 52 (7.3) | 59 (54.1) | <0.001 | 23 (10.6) | 59 (54.1) | < 0.001 |
| Cognitive impairment, n (%) | 13 (1.8) | 13 (11.9) | <0.001 | 6 (2.8) | 13 (11.9) | 0.001 |
| Deep vein thrombosis (DVT), n (%) | 23 (3.2) | 8 (7.3) | 0.036 | 9 (4.1) | 8 (7.3) | 0.218 |
| Hemorrhagic transformation, n (%) | 23 (3.2) | 3 (2.8) | 0.788 | 7 (3.2) | 3 (2.8) | 0.821 |
| Stroke recurrence, n (%) | 62 (8.7) | 7 (6.4) | 0.421 | 27 (12.4) | 7 (6.4) | 0.096 |
| In-hospital death, n (%) | 54 (7.6) | 26 (23.9) | <0.001 | 22 (10.1) | 26 (23.9) | 0.001 |